“Immune microenvironment in high-grade serous ovarian carcinomas: association with molecular profiles and neoadjuvant therapy outcome” (2023) Voprosy onkologii, 69(1), pp. 74–81. doi:10.37469/0507-3758-2023-69-1-74-81.